HR 3490: Gerald E. Connolly Esophageal Cancer Awareness Act of 2025

HR 3490 in plain English: This law requires the Government Accountability Office to report to Congress on esophageal cancer-related health care spending under the Federal Employees Health Benefits Program and how often high-risk participants receive recommended cancer screenings.

Stated purpose

This bill requires the Government Accountability Office (GAO) to study and report to Congress on esophageal cancer costs and screening rates within the Federal Employees Health Benefits Program (FEHBP), in order to raise awareness and inform policymakers about this disease.

Key points

• Directs the GAO to study esophageal cancer-related health care spending for federal employees and retirees covered by FEHBP
• Requires the GAO to examine how often high-risk FEHBP participants receive esophageal cancer screenings per established guidelines

Arguments supporters make

• Esophageal cancer is one of the deadliest and fastest-growing cancers, and collecting data on screening rates could help identify gaps that, if addressed, save lives through earlier detection.
• The bill costs little — it only requires a study — yet could provide valuable information about whether federal workers at high risk are actually receiving the screenings their doctors recommend.
• Early detection of esophageal cancer's precursor condition can lead to cure rates as high as 49 percent at five years, so understanding barriers to screening is a meaningful step toward better outcomes.

Arguments opponents make

• The bill only mandates a report and takes no direct action, so it may not lead to any real change in screening rates or cancer outcomes for those at risk.
• Focusing the study solely on federal employees and retirees covered by FEHBP limits the findings, leaving out the vast majority of Americans who face the same disease but are covered by different insurance.
• Congress already has access to substantial public health data on cancer; critics may see this as duplicating existing research without a clear plan to act on whatever the GAO finds.

Tradeoffs

The bill gathers potentially useful data at low cost but applies only to a narrow population of federal workers, meaning findings may not reflect or help the broader American public facing esophageal cancer. Requiring a study also does not guarantee any follow-up action to improve screening or reduce deaths.

Current status in Congress: Became law.

NewsClear — neutral news & congressional tracking · Bill of the Week